Latest News Archive

Please select Category, Year, and then Month to display items

Fighting COVID-19: Here is how we are helping

16 April 2020 | Story Department of Communication and Marketing | Photo Charl Devenish

Farmovs — In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.

The University of the Free State (UFS) is committed to supporting government’s efforts to overcome the COVID-19 pandemic. During this challenging time, dedicated staff members at the UFS continue to provide services as a testimony to their commitment to advance public knowledge of COVID-19 for the greater good of South Africa.

The following is a synopsis of the areas in which the UFS is actively assisting.

Public Health Emergency Solidarity Trial
Clinicians from the Department of Internal Medicine, the Department of Critical Care, and the Division of Virology will be working with FARMOVS to participate in the Public Health Emergency Solidarity Trial initiated by the World Health Organization (WHO). This international randomised trial will evaluate four treatment options (remdesivir, lopinavir/ritonavir, lopinavir/ritonavir plus interferon, chloroquine or hydroxychloroquine) for the treatment of COVID-19.

The trial is expected to include more than 45 countries worldwide, including a number of South African sites.

Farmovs
FARMOVS is in a planning process to support all the Bloemfontein hospitals, including Pelonomi, Universitas, 3 Military Hospital, Mediclinic, and Rosepark, in conducting the largest global trial on COVID-19 – the Public Health Emergency Solidarity Trial, under leadership of the WHO.

Negotiations are ongoing between the UFS and the Department of Health in the Free State for FARMOVS to offer support with the continuation of healthcare to non-COVID-19 patients in an attempt to free up space at Universitas Hospital for isolation of COVID-19 patients.

In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe. FARMOVS also receives feasibility requests for support with the evaluation of existing drugs (repurposing) as well as the development of novel drugs for the treatment of COVID-19 – this is an ongoing process.

Disaster Management Training and Education Centre (DiMTEC)
DiMTEC represents the UFS on the Provincial Joint Operation Centre (PROVJOC). The PROVJOC is a fully equipped, dedicated facility that is proactively established to enable all relevant role players /disciplines to jointly manage all safety and security-related aspects of any planned event or any major incident which has occurred or is imminent – especially in the response and recovery operations phase – at the strategic and/or tactical level, using the Unified Command System. This facility is also linked to all other established safety and security centres.

Research and Innovation
The UFS hosts a SARChI Research Chair in vector-borne and zoonotic diseases, and recently invested in the establishment of a biosafety level-3 facility. Hence, there is expertise on the campus to plan and conduct research on zoonotic and medically significant viruses. In addition, there are research groups focusing on protein expression systems with potential for utilisation in the development of diagnostic assays with application in either diagnosis or surveillance.

Currently, researchers at the UFS have established several projects that will contribute directly towards the COVID-19 outbreak.

News Archive

International Bible scholars attend conference on Apocalyptic Literature and Mysticism

2017-09-18

Prof Francis Petersen, UFS Rector and Vice-Chancellor,
second from left, flanked by three
deans of theology: Prof Fanie Snyman (UFS),
Prof Jörg Frey (University of Zurich),
and Prof Gregory Sterling (Yale Divinity School).
Photo: Eugene Seegers

Apocalypticism and mysticism have become two key areas of research that have converged to form the heart of contemporary spirituality. It was with this in mind that leading local and international Bible scholars were invited to a collaborative international conference jointly hosted by the UFS Faculty of Theology and Religion and Yale Divinity School, with the theme Apocalyptic Literature and Mysticism—Investigating a Turn in Recent Apocalyptic Research.

It is perhaps unknown to many that a number of the most profound thinkers, both of Judeo-Christian tradition and other religions in general, were mystics. Their lives and writings speak of a longing for an intimate relationship with God, reflecting on universal existential questions such as understanding our human existence, our creation, and ultimately, the meaning of life.

Apocalypticism, on the other hand, focuses on texts and prophecies describing how an alternative, future world might replace our existing one, a process often cataclysmic in nature, thus, like the mystics, also reflecting on the deeper foundations of human existence and our possible demise.

Traditionally, both have been misunderstood and controversial, but more recent research has revealed their formative role in religious discourses, with many scholars finding growing commonalities between apocalyptic and mystical texts. Moreover, these commonalities help to establish a better understanding of Judeo-Christian traditions, as well as other religions in general.

This hugely successful UFS collaborative effort, as well as others of its kind, contribute to the growth of theology as a discipline, with a positive impact on the broader religious community, the church, and society as a whole in the common desire for a just, equitable, and humane world.

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept